Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celldex Therapeutics (CLDX) Goodwill (2016 - 2017)

Celldex Therapeutics (CLDX) has 8 years of Goodwill data on record, last reported at $91.0 million in Q4 2017.

  • For Q4 2017, Goodwill changed 0.0% year-over-year to $91.0 million; the TTM value through Dec 2017 reached $91.0 million, changed 0.0%, while the annual FY2017 figure was $91.0 million, 0.0% changed from the prior year.
  • Goodwill reached $91.0 million in Q4 2017 per CLDX's latest filing, roughly flat from $91.0 million in the prior quarter.
  • Across five years, Goodwill topped out at $91.0 million in Q4 2016 and bottomed at $9.0 million in Q1 2013.
  • Average Goodwill over 5 years is $22.6 million, with a median of $9.0 million recorded in 2013.
  • Peak YoY movement for Goodwill: changed 0.0% in 2013, then soared 914.79% in 2016.
  • A 5-year view of Goodwill shows it stood at $9.0 million in 2013, then changed by 0.0% to $9.0 million in 2014, then changed by 0.0% to $9.0 million in 2015, then skyrocketed by 914.79% to $91.0 million in 2016, then changed by 0.0% to $91.0 million in 2017.
  • Per Business Quant database, its latest 3 readings for Goodwill were $91.0 million in Q4 2017, $91.0 million in Q3 2017, and $91.0 million in Q4 2016.